The TISCH study proved that CDCA5 was moderately expressed in immune cells and had a strong association with proliferating T cells, indicating that CDCA5 was implicated in the immune regulatory network by enhancing immune activation in colorectal cancer. The gene discussed is CDCA5; the disease is colorectal cancer.